Spyre Therapeutics Inc (SYRE)

Common Stock

$16.00K

Quarterly · Period ending: · USD

SYRE logo

SYRE Common Stock

Latest reported$16.00K
SYRE Quarterly Common Stock ($811.00K → $16.00K)
High-resolution chart · PNG

SYRE common stock history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Common Stock — Quarterly (USD)
Period endingCommon Stock (USD)
16,000
15,000
15,000
13,000
13,000
13,000
13,000
12,000
12,000
10,000
10,000
7,000
6,000
6,000
6,000
6,000
6,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
3,000
3,000
3,000
3,000
3,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
1,000
1,000
1,000
1,000
0
0
1,000
1,000
1,000
811,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.